Home
Morrison & Foerster LLP
Wolfgang Schönig
Wolfgang Schönig
Morrison & Foerster LLP
EU MDR And IVDR Implementation: European Commission Publishes Full Proposal For Amending Transitional Regime
20 Jan 2023 | European Union
EU MDR And IVDR Implementation: Signs Of Relaxing Transitioning Regime And Bridging Measures
23 Dec 2022 | European Union
In Vitro Diagnostic Regulation Entered Into Force (Part 2 Of 3)
07 Jun 2022 | European Union
In Vitro Diagnostic Regulation Entered Into Force (Part 1 Of 3)
01 Jun 2022 | European Union
A Long Courtship For Unity – As Europe's Unitary Patent System Is Going Live Soon, Consultations About A Unitary Supplementary Protection Certificate Gain Momentum
13 Apr 2022 | European Union
Am Geld Wird Es Jedenfalls Nicht Scheitern
14 Dec 2021 | Germany
At Any Rate, It Won't Fail Because Of Money
10 Dec 2021 | Germany
Recent Developments Regarding Patent Injunctions In Germany
25 Jun 2021 | Germany
How Will Europe's New Device Regulations Affect Medical Software?
11 Jun 2021 | European Union
The European Commission's Take On Novel Genomic Techniques (NGTs) In Light Of CJEU's Ruling In Case C-528/16
31 May 2021 | European Union
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 6 Of 6)
14 Apr 2021 | United States
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 5 Of 6)
25 Mar 2021 | United States
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 4 Of 6)
15 Mar 2021 | United States
Key EU Intellectual Property And Trade Secrets
05 Mar 2021 | European Union
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 3 Of 6)
01 Mar 2021 | United States
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 2 Of 6)
23 Feb 2021 | European Union
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 1 Of 6)
15 Feb 2021 | United States
Top 10 Considerations When Drafting And Negotiating Sras, With U.S. And EU Perspectives
21 Jan 2021 | United States
The European Commission's New Pharmaceutical Strategy For Europe
23 Dec 2020 | European Union
Huawei v. ZTE Revisited – German Automotive Patent Wars To Reshape SEP Litigation In Europe
17 Dec 2020 | European Union
< 1 2 >
Contact Details
Berlin
Email Website
Potsdamer Platz 1
13th Floor
Berlin
Germany
Telephone: 49-415-2687000

  © Mondaq® Ltd 1994 - 2023. All Rights Reserved.